EP1328298A4 - Procedes et compositions servant a moduler l'activation des lymphocytes t et leurs utilisations - Google Patents

Procedes et compositions servant a moduler l'activation des lymphocytes t et leurs utilisations

Info

Publication number
EP1328298A4
EP1328298A4 EP01981352A EP01981352A EP1328298A4 EP 1328298 A4 EP1328298 A4 EP 1328298A4 EP 01981352 A EP01981352 A EP 01981352A EP 01981352 A EP01981352 A EP 01981352A EP 1328298 A4 EP1328298 A4 EP 1328298A4
Authority
EP
European Patent Office
Prior art keywords
modulating
compositions
methods
cell activation
activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01981352A
Other languages
German (de)
English (en)
Other versions
EP1328298A1 (fr
Inventor
Anthony Montgomery
Larissa Balaian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Scripps Research Institute
Original Assignee
University of California
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, Scripps Research Institute filed Critical University of California
Publication of EP1328298A1 publication Critical patent/EP1328298A1/fr
Publication of EP1328298A4 publication Critical patent/EP1328298A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1777—Integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
EP01981352A 2000-10-02 2001-10-02 Procedes et compositions servant a moduler l'activation des lymphocytes t et leurs utilisations Withdrawn EP1328298A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23755500P 2000-10-02 2000-10-02
US237555P 2000-10-02
PCT/US2001/030864 WO2002028440A1 (fr) 2000-10-02 2001-10-02 Procedes et compositions servant a moduler l'activation des lymphocytes t et leurs utilisations

Publications (2)

Publication Number Publication Date
EP1328298A1 EP1328298A1 (fr) 2003-07-23
EP1328298A4 true EP1328298A4 (fr) 2005-05-04

Family

ID=22894231

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01981352A Withdrawn EP1328298A4 (fr) 2000-10-02 2001-10-02 Procedes et compositions servant a moduler l'activation des lymphocytes t et leurs utilisations

Country Status (5)

Country Link
EP (1) EP1328298A4 (fr)
JP (1) JP2004531457A (fr)
AU (1) AU2002213001A1 (fr)
CA (1) CA2423436A1 (fr)
WO (1) WO2002028440A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA42043A (fr) 2015-05-07 2018-03-14 Agenus Inc Anticorps anti-ox40 et procédés d'utilisation de ceux-ci
CN116063542A (zh) 2015-12-02 2023-05-05 阿吉纳斯公司 抗体和其使用方法
CA3041340A1 (fr) 2016-11-09 2018-05-17 Agenus Inc. Anticorps anti-ox40, anticorps anti-gitr, et leurs procedes d'utilisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
EP1328298A1 (fr) 2003-07-23
AU2002213001A1 (en) 2002-04-15
CA2423436A1 (fr) 2002-04-11
JP2004531457A (ja) 2004-10-14
WO2002028440A1 (fr) 2002-04-11
WO2002028440B1 (fr) 2002-05-30

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2002225681A1 (en) Yeast-dentritic cell vaccines and uses thereof
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU6832101A (en) Composition and method
AU4163402A (en) Composition and method
AU2001251137A1 (en) Methods and products for regulating cell motility
AU2002211717A1 (en) Stresscopins and their uses
AU2002213466A1 (en) Compounds and methods for modulating ccr4 function
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2001293074A1 (en) Human liver cell line
AU2001233932A1 (en) Method and composition
AU2001269803A1 (en) Compositions and methods for modulating muscle cell and tissue contractility
AU2002364612A8 (en) Methods and materials for modulating enac-beta
EP1328298A4 (fr) Procedes et compositions servant a moduler l'activation des lymphocytes t et leurs utilisations
GB9922135D0 (en) Compositions and uses
GB0102717D0 (en) Cells and uses therefor
AU8975701A (en) Novel composition and use
AU2002239775A1 (en) Chemical-library composition and method
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
EP1287362A4 (fr) Compositions et methodes destinees a la modulation de l'expression specifique des tumeurs
AU2002214307A1 (en) T cell line and use thereof
AU2001249194A1 (en) Immunokine composition and method
AU5931300A (en) Ringene compositions and methods for use thereof
AU6627800A (en) Methods and compositions for modulating somatolactogenic functions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030502

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Owner name: THE SCRIPPS RESEARCH INSTITUTE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Owner name: THE SCRIPPS RESEARCH INSTITUTE

A4 Supplementary search report drawn up and despatched

Effective date: 20050321

17Q First examination report despatched

Effective date: 20060920

17Q First examination report despatched

Effective date: 20060920

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070829